Article
Facilitating EMA binding test performance using fluorescent beads combined with next‐generation sequencing
9 Sept 2021
Abstract excerpt
Abstract The eosin‐5′‐maleimide (EMA) binding test is widely used as diagnostic test for hereditary spherocytosis (HS), one of the most common haemolytic disorders in Caucasian populations. We recently described the advantages of replacing the use of healthy control blood samples with fluorescent beads in a modified EMA binding assay. In this study we further explore this novel approach. We performed targeted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
